Needham & Company Upgrades CryoLife (CRY) to Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/10/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
Tweet
Share
E-mailGet Alerts CRY Hot Sheet
Price: $15.61 +0.06%
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Rating Summary:
6 Buy, 3 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 14 | New: 37
Join SI Premium – FREE
Needham & Company analyst Matt Matson upgraded CryoLife (NYSE: CRY) from Hold to Buy.
For an analyst ratings summary and ratings history on CryoLife click here. For more ratings news on CryoLife click here.
Shares of CryoLife closed at $24.64 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Downgrades Pacira Pharmaceuticals (PCRX) to Hold
- The Elmet Group (ELMT) PT Raised to $28 at Needham
- Zeta Global Holdings Corp (ZETA) PT Raised to $40 at Needham
Create E-mail Alert Related Categories
UpgradesRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
